Abstract
Cystic adenoid carcinoma (CAC) is a rare tumor, accounting for about 1% of all head and neck malignancies and about 10% of all salivary gland tumors. Although they grow slowly, CACs have a progressive and infiltrative clinical course and can develop rapidly occurring metastases in high-grade disease. CACs are known to be difficult tumors to treat, especially because of their resistance to…